111 related articles for article (PubMed ID: 1700221)
1. Influence of ramipril on right ventricular hypertrophy induced by pulmonary artery stenosis in rats.
Zierhut W; Zimmer HG; Gerdes AM
J Cardiovasc Pharmacol; 1990 Sep; 16(3):480-6. PubMed ID: 1700221
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats.
Zierhut W; Zimmer HG; Gerdes AM
Circ Res; 1991 Sep; 69(3):609-17. PubMed ID: 1714799
[TBL] [Abstract][Full Text] [Related]
3. Development and modulation of experimental right ventricular hypertrophy in rats.
Zimmer HG
J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S1-6. PubMed ID: 1380611
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the renin-angiotensin system and insulin-like growth factor I in aorto-caval fistula-induced cardiac hypertrophy in rats.
Wåhlander H; Wickman A; Isgaard J; Friberg P
Acta Physiol Scand; 1999 Feb; 165(2):143-54. PubMed ID: 10090325
[TBL] [Abstract][Full Text] [Related]
5. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
Mohabir R; Young SD; Strosberg AM
J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte loss in experimental renal failure: prevention by ramipril.
Amann K; Tyralla K; Gross ML; Schwarz U; Törnig J; Haas CS; Ritz E; Mall G
Kidney Int; 2003 May; 63(5):1708-13. PubMed ID: 12675846
[TBL] [Abstract][Full Text] [Related]
7. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E
Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
[TBL] [Abstract][Full Text] [Related]
8. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
Linz W; Schölkens BA; Ganten D
Clin Exp Hypertens A; 1989; 11(7):1325-50. PubMed ID: 2530011
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation.
Koide M; Carabello BA; Conrad CC; Buckley JM; DeFreyte G; Barnes M; Tomanek RJ; Wei CC; Dell'Italia LJ; Cooper G; Zile MR
Am J Physiol; 1999 Feb; 276(2 Pt 2):H350-8. PubMed ID: 9950833
[TBL] [Abstract][Full Text] [Related]
10. [Right ventricular hypertrophy in rats: effect of ACE inhibitors].
Zimmer HG; Zierhut W
Klin Wochenschr; 1991; 69 Suppl 24():30-8. PubMed ID: 1830910
[TBL] [Abstract][Full Text] [Related]
11. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril.
Linz W; Schölkens BA
Br J Pharmacol; 1992 Apr; 105(4):771-2. PubMed ID: 1324047
[TBL] [Abstract][Full Text] [Related]
12. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Ruzicka M; Yuan B; Harmsen E; Leenen FH
Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
[TBL] [Abstract][Full Text] [Related]
13. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system.
Grimm D; Elsner D; Schunkert H; Pfeifer M; Griese D; Bruckschlegel G; Muders F; Riegger GA; Kromer EP
Cardiovasc Res; 1998 Jan; 37(1):91-100. PubMed ID: 9539862
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of the converting enzyme inhibitor ramipril (HOE 498) in anesthetized dogs with acute ischemic left ventricular failure.
Schölkens BA; Martorana PA; Göbel H; Gehring D
Clin Exp Hypertens A; 1986; 8(6):1033-48. PubMed ID: 3019594
[TBL] [Abstract][Full Text] [Related]
15. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
Clauser E
Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the renin-angiotensin system and the endothelin system in cardiac hypertrophy.
Stula M; Pinto YM; Gschwend S; Teisman AC; van Gilst WH; Böhm M; Dietz R; Paul M
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S403-5. PubMed ID: 9595497
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
Linz W; Henning R; Schölkens BA
J Hypertens Suppl; 1991 Dec; 9(6):S400-1. PubMed ID: 1840203
[No Abstract] [Full Text] [Related]
18. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production.
Ogawa T; Linz W; Stevenson M; Bruneau BG; Kuroski de Bold ML; Chen JH; Eid H; Schölkens BA; de Bold AJ
Circulation; 1996 Jun; 93(11):2059-67. PubMed ID: 8640983
[TBL] [Abstract][Full Text] [Related]
19. Cardiac renin-angiotensin system: role in development of pressure-overload hypertrophy.
Lorell BH
Can J Cardiol; 1995 Aug; 11 Suppl F():7F-12F. PubMed ID: 7664219
[TBL] [Abstract][Full Text] [Related]
20. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
